GlassScriptPhysician profile
John C Hildenbrand
NPI 1174662936
$1,392.71
in general payments reported to CMS, 2019-2025
20 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $257 · 2021: $272 · 2022: $160 · 2023: $135 · 2024: $144 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $178.09 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $166.60 | 2021-2024 | Xiaflex |
| Pacira Therapeutics, INC. | $142.41 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $129.26 | 2019-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $117.84 | 2019 | |
| Stryker Corporation | $115.95 | 2020-2025 | 1788 |
| Trice Medical, INC. | $114.27 | 2020 | |
| Endo USA, INC. | $99.36 | 2024-2025 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $75.93 | 2020-2024 | Exparel, Zilretta, Iovera |
| Kowa Pharmaceuticals America, INC. | $46.35 | 2022-2023 | Seglentis |
| Horizon Therapeutics Plc | $41.89 | 2019 | |
| Abbvie INC. | $27.42 | 2021-2022 | |
| Davol INC. | $26.26 | 2022 | |
| Vericel Corporation | $18.55 | 2020 | |
| Kerecis Limited | $17.83 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $16.52 | 2024 | Topical Oxygen Chamber For Extremities |
| Amgen INC. | $16.50 | 2020 | |
| Abbott Laboratories | $16.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.77 | 2019 | |
| Pfizer INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$351.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hildenbrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.